Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Revance Therapeutics, Inc. (RVNC) > Segments

Product

Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  76.514.90.43.7    
            Revenue growth  413.0%3509.7%-88.9%     
EBIT  -136.0-160.0-110.4-94.2    
            EBIT margin  -177.8%-1073.5%-26724.2%-2525.8%    
   
Revenue Mix  98.3%97.3%100.0%100.0%    

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy